Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

IK induced by coxsackievirus B3 infection transiently downregulates expression of MHC class II through increasing cAMP.

Park HL, Kim YJ, Na HN, Park MY, Kim JY, Yun CW, Nam JH.

Viral Immunol. 2013 Feb;26(1):13-24. doi: 10.1089/vim.2012.0054.

PMID:
23409929
[PubMed - indexed for MEDLINE]
2.

gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis.

Huber SA, Stone JE, Wagner DH Jr, Kupperman J, Pfeiffer L, David C, O'Brien RL, Davis GS, Newell MK.

J Virol. 1999 Jul;73(7):5630-6.

PMID:
10364312
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL.

J Virol. 2001 Mar;75(5):2377-87.

PMID:
11160741
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3.

Seko Y, Tsuchimochi H, Nakamura T, Okumura K, Naito S, Imataka K, Fujii J, Takaku F, Yazaki Y.

Circ Res. 1990 Aug;67(2):360-7.

PMID:
2165443
[PubMed - indexed for MEDLINE]
Free Article
5.

Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.

Leipner C, Borchers M, Merkle I, Stelzner A.

J Hum Virol. 1999 Mar-Apr;2(2):102-14.

PMID:
10225212
[PubMed - indexed for MEDLINE]
6.

Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.

Kemball CC, Harkins S, Whitmire JK, Flynn CT, Feuer R, Whitton JL.

PLoS Pathog. 2009 Oct;5(10):e1000618. doi: 10.1371/journal.ppat.1000618. Epub 2009 Oct 16.

PMID:
19834548
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS.

Infect Immun. 1983 Feb;39(2):851-64.

PMID:
6299950
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii.

Lüder CG, Lang T, Beuerle B, Gross U.

Clin Exp Immunol. 1998 May;112(2):308-16.

PMID:
9649196
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.

Jarasch-Althof N, Wiesener N, Schmidtke M, Wutzler P, Henke A.

Viral Immunol. 2010 Aug;23(4):369-76. doi: 10.1089/vim.2010.0018.

PMID:
20712481
[PubMed - indexed for MEDLINE]
10.

The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.

Leipner C, Grün K, Borchers M, Stelzner A.

Herz. 2000 May;25(3):245-8.

PMID:
10904846
[PubMed - indexed for MEDLINE]
11.

Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.

St Pierre Y, Watts TH.

J Immunol. 1991 Nov 1;147(9):2875-82.

PMID:
1680921
[PubMed - indexed for MEDLINE]
12.

Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice.

Nakamura H, Yamamura T, Umemoto S, Fukuta S, Shioi T, Matsumori A, Sasayama S, Matsuzaki M.

Circulation. 1996 Dec 15;94(12):3348-54.

PMID:
8989150
[PubMed - indexed for MEDLINE]
Free Article
13.

A phenotypically dominant regulatory mechanism suppresses major histocompatibility complex class II gene expression in a murine plasmacytoma.

Venkitaraman AR, Culbert EJ, Feldmann M.

Eur J Immunol. 1987 Oct;17(10):1441-6.

PMID:
3500056
[PubMed - indexed for MEDLINE]
14.

MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.

Held W, Waanders GA, MacDonald HR, Acha-Orbea H.

Int Immunol. 1994 Sep;6(9):1403-7.

PMID:
7819149
[PubMed - indexed for MEDLINE]
15.
16.

Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.

Huber S, Song WC, Sartini D.

Viral Immunol. 2006 Summer;19(2):156-66.

PMID:
16817758
[PubMed - indexed for MEDLINE]
17.

Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Rehm KE, Connor RF, Jones GJ, Yimbu K, Mannie MD, Roper RL.

Immunology. 2009 Nov;128(3):381-92. doi: 10.1111/j.1365-2567.2009.03120.x.

PMID:
20067538
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.

Heise MT, Pollock JL, O'Guin A, Barkon ML, Bormley S, Virgin HW 4th.

Virology. 1998 Feb 15;241(2):331-44.

PMID:
9499808
[PubMed - indexed for MEDLINE]
19.

MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region.

Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, Zhong Z.

Antiviral Res. 2012 Feb;93(2):270-9. doi: 10.1016/j.antiviral.2011.12.004. Epub 2011 Dec 13.

PMID:
22197249
[PubMed - indexed for MEDLINE]
20.

Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.

Lan J, Gao Z, Xiong H, Chuai X, Jin Y, Li J, Xian X, Liu G, Xie L, Zhang Y, Wang Y.

Vaccine. 2011 Sep 16;29(40):6894-902. doi: 10.1016/j.vaccine.2011.07.049. Epub 2011 Jul 29.

PMID:
21803097
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk